Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity
Abstract Neurotoxicity caused by cisplatin is a major obstacle during chemotherapy. Oxidative stress and inflammation are considered the primary mechanism behind neuronal damage which affects the continuing chemotherapy regimen. Agomelatine was recently described as a neuroprotective compound against toxic insults in the nervous systems. It is an analog of the well-known antioxidant and anti-inflammatory compound melatonin and currently used for depression and sleep disturbances. In the current study, we investigated the possible neuroprotective role of agomelatine against cisplatin-induced oxidative, inflammatory, and behavioral alterations in male rats. Our results show that agomelatine prevented cisplatin-induced neurotoxicity in the HT-22 mouse hippocampal neuronal cell line. Additionally, agomelatine treatment inhibited cisplatin-induced behavioral deficits and neuronal integrity in vivo. For the evaluation of the effect of agomelatine on oxidative stress and inflammation, GSH, MDA, TNF, and IL-6 levels were analyzed in HT-22 cells and hippocampal tissues. Agomelatine significantly attenuated oxidative stress and inflammation due to the cisplatin insult in vitro and in vivo. Also, agomelatine treatment ameliorated the neuronal pathology in the hippocampus, which is strongly related to cognition and memory. Taken together, our results indicate that in males, the neuroprotective effect of agomelatine is mediated through its antioxidant and anti-inflammatory actions abrogating functional deficits..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Metabolic brain disease - 36(2020), 2 vom: 09. Nov., Seite 339-349 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cankara, Fatma Nihan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Agomelatine |
| Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2020 |
|---|
| doi: |
10.1007/s11011-020-00634-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2122820578 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2122820578 | ||
| 003 | DE-627 | ||
| 005 | 20230505065740.0 | ||
| 007 | tu | ||
| 008 | 230505s2020 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11011-020-00634-y |2 doi | |
| 035 | |a (DE-627)OLC2122820578 | ||
| 035 | |a (DE-He213)s11011-020-00634-y-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.00$jMedizin: Allgemeines |2 bkl | ||
| 100 | 1 | |a Cankara, Fatma Nihan |e verfasserin |0 (orcid)0000-0002-2367-6412 |4 aut | |
| 245 | 1 | 0 | |a Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2020 | ||
| 520 | |a Abstract Neurotoxicity caused by cisplatin is a major obstacle during chemotherapy. Oxidative stress and inflammation are considered the primary mechanism behind neuronal damage which affects the continuing chemotherapy regimen. Agomelatine was recently described as a neuroprotective compound against toxic insults in the nervous systems. It is an analog of the well-known antioxidant and anti-inflammatory compound melatonin and currently used for depression and sleep disturbances. In the current study, we investigated the possible neuroprotective role of agomelatine against cisplatin-induced oxidative, inflammatory, and behavioral alterations in male rats. Our results show that agomelatine prevented cisplatin-induced neurotoxicity in the HT-22 mouse hippocampal neuronal cell line. Additionally, agomelatine treatment inhibited cisplatin-induced behavioral deficits and neuronal integrity in vivo. For the evaluation of the effect of agomelatine on oxidative stress and inflammation, GSH, MDA, TNF, and IL-6 levels were analyzed in HT-22 cells and hippocampal tissues. Agomelatine significantly attenuated oxidative stress and inflammation due to the cisplatin insult in vitro and in vivo. Also, agomelatine treatment ameliorated the neuronal pathology in the hippocampus, which is strongly related to cognition and memory. Taken together, our results indicate that in males, the neuroprotective effect of agomelatine is mediated through its antioxidant and anti-inflammatory actions abrogating functional deficits. | ||
| 650 | 4 | |a Agomelatine | |
| 650 | 4 | |a Cisplatin | |
| 650 | 4 | |a Neurotoxicity | |
| 650 | 4 | |a Hippocampus | |
| 650 | 4 | |a HT-22 cell line | |
| 650 | 4 | |a Wistar-albino rat | |
| 700 | 1 | |a Günaydın, Caner |0 (orcid)0000-0002-8304-832X |4 aut | |
| 700 | 1 | |a Çelik, Zülfinaz Betül |0 (orcid)0000-0003-1390-7309 |4 aut | |
| 700 | 1 | |a Şahin, Yasemin |0 (orcid)0000-0003-4226-674X |4 aut | |
| 700 | 1 | |a Pekgöz, Şakir |4 aut | |
| 700 | 1 | |a Erzurumlu, Yalçın |0 (orcid)0000-0001-6835-4436 |4 aut | |
| 700 | 1 | |a Gülle, Kanat |0 (orcid)0000-0002-6337-8962 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Metabolic brain disease |d Springer US, 1986 |g 36(2020), 2 vom: 09. Nov., Seite 339-349 |w (DE-627)168086751 |w (DE-600)632824-6 |w (DE-576)518182371 |x 0885-7490 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2020 |g number:2 |g day:09 |g month:11 |g pages:339-349 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11011-020-00634-y |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 936 | b | k | |a 44.00$jMedizin: Allgemeines |q VZ |0 106409646 |0 (DE-625)106409646 |
| 951 | |a AR | ||
| 952 | |d 36 |j 2020 |e 2 |b 09 |c 11 |h 339-349 | ||